BANGKOK, Thailand (AP) - The head of the UN health agency said Tuesday negotiations are underway to build a stockpile of avian-flu fighting drugs for Southeast Asia to help guard against a potential global flu pandemic.
Dr. Lee Jong-wook said the World Health Organization hopes to initially acquire one million doses of the anti-viral Tamiflu, which is the only drug known to be effective against avian influenza in humans. He said talks are underway with other countries and Swiss drug manufacturer Hoffmann-La Roche Inc. to allow the medicine to be distributed to poor countries for free or at highly discounted rates.
Currently WHO has only enough Tamiflu to treat about 125,000 people, he said.
"Clearly for us and for others this is very important; to deal with the problem at the source," he told reporters in Bangkok where he was attending a global conference on health promotion. "WHO has a very limited stock. We want to increase the stockpile and we would like to deploy this to countries in this region."
Lee also warned that it makes no sense for wealthy countries to horde large volumes of either the drug Tamiflu or an experimental vaccine that has recently shown promise in humans.
He said the best way to control the virus if it begins spreading among humans is to hit it hard at the source, with wealthier countries sharing their drugs. The United States already has enough Tamiflu to treat 2.3 million people and is working to acquire more, while Britain, France, Finland, Norway and New Zealand are placing orders that would cover between 20 per cent and 40 per cent of their populations.
The story is from Canada.com. The claim that early decisive action can stop bird flu if its caught early on is not new. Regardless of the controversy surrounding the idea, the decision by the WHO to have its own stockpile ready for rapid deployment in East Asia is welcome. The call for rich countries to stop their "hoarding" is a bit strange. Large orders from these countries will likely increase production capacity, surely a good thing in the medium to long run.